Obeticholic acid (OCA), which is a synthetic bile acid derivative and farnesoid X receptor agonist, was recently found to reduce hepatic inflammation and improve the histological features of NASH (153). The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatohepatitis.